Phibro Animal Health Corporation (PAHC)
Phibro (PAHC) Reliance on International Sales: What Investors Need to Know
Review Phibro's (PAHC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase
Phibro's second-quarter fiscal 2025 results reflect the strong performance of the legacy Animal Health business.
Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript
Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript
Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.33 per share a year ago.
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
All You Need to Know About Phibro (PAHC) Rating Upgrade to Strong Buy
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
